SARS-Coronavirus-2 Research Reagents
More Areas of SARS-CoV-2 Research
SARS-CoV-2 Variants Research Reagents
The use of the ProSci Spike Antibody (Cat. No. 3525) has been cited in numerous publications in 2020 and 2021. Of great interest now, while ProSci offers antibodies and recombinant proteins representing the full SARS-CoV-2 proteome, and host factors, the company also has a catalog of spike S1 antibodies to variant SARS-CoV-2 B.1.1.7 (Alpha) to the P681H point mutation (Cat. No. 9359) – this residue is adjacent to the Furin cleavage site, required for viral cell entry.
COVID-19 Patient Sample Validated Antibodies
ProSci enhances research efforts globally to understand this virus and its health effects. We have validated antibodies to all four structural proteins and several non-structural SARS-CoV-2 proteins by IHC with COVID-19 positive patient tissue samples, showing that these antibodies can detect the virus itself.
Matched Pair Antibodies
ProSci offers SARS-CoV-2 antibody pairs validated by sandwich ELISA. These matched pair antibodies include antibodies against Spike S1, Spike RBD, and Nucleocapsid proteins. Some of the antibodies have been validated with COVID-19 patient samples.
Single Domain Antibodies
ProSci offers recombinant single domain antibodies for SARS-CoV-2 Spike S1 and S2. Contact ProSci to discuss your sdAb target and detection needs.